Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PerkinElmer Inc (NYSE:PKI)

54.98
Delayed Data
As of 4:02pm ET
 +1.08 / +2.00%
Today’s Change
39.50
Today|||52-Week Range
55.16
+2.63%
Year-to-Date
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
May 17 / Zacks.com - Paid Partner Content
Moving Average Crossover Alert: PerkinElmer (PKI)
May 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close53.90
Today’s open54.20
Day’s range53.95 - 55.16
Volume815,641
Average volume (3 months)830,905
Market cap$5.9B
Dividend yield0.51%
Data as of 4:02pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+34.88%
Earnings growth (this year)+9.55%
Earnings growth (next 5 years)+9.85%
Revenue growth (last year)+1.12%
P/E ratio28.2
Price/Sales2.68
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
QGENQiagen NV-0.42-1.96%
BRKRBruker Corp+0.49+1.87%
FEICFEI Co+3.40+3.78%
BIOBio Rad Laboratories...+3.90+2.71%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.65
Annual revenue (last year)$2.3B
Annual profit (last year)$212.5M
Net profit margin9.40%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Robert F. Friel
Chief Financial Officer &
Senior Vice President
Andy Wilson
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs